The below clickable headlines link directly to outside media outlets, which featured UNC School of Medicine faculty starting Friday, March 28, 2025.
What’s driving access improvements? 4 leaders weigh in – Dr. Wesley Burks (Becker’s Hospital Review)
ASOD researcher explores antibiotic resistance in diabetic patients – Dr. Brian Conlon (Dentistry33)
Effective antibiotic for maternal sepsis saves health care costs, study finds – Dr. Jackie Patterson, Dr. Melissa Bauserman (Medical Xpress)
Oral semaglutide vastly reduces heart attacks, strokes in people with type 2 diabetes – Dr. John Buse (EurekAlert!)
SOUL Findings Highlight Cardiovascular Benefits Beyond Glycemic Control With Oral GLP-1 – Dr. John Buse (American Journal of Managed Care)
Oral Semaglutide Significantly Decreases Incidence of Heart Attacks and Strokes in Type 2 Diabetes Patients – Dr. John Buse (Bioengineer.org)
Best Ways to Stop Muscle Pain – Dr. John Batsis (Consumer Reports)
The Colorado psychedelic mushroom experiment has arrived – Dr. William R. Smith (The Grand Junction Daily Sentinel)
NC House bill would expand access to early screening for prostate cancer – Dr. Matthew Nielsen (The Robesonian)
Podcast: What We Talk About When We Talk About SNAP w/ Seth Berkowitz – Dr. Seth Berkowitz (RamaOnHealthcare)
In Depth with Dan: Answering viewer questions about THC drinks – Dr. Zoe McElligott (WRAL-TV)
Parkgoers balance spring break with ‘really horrible’ pollen – Dr. Edwin Kim (WTVD)
NC health experts offer tips on how to combat pollen allergies – Dr. Edwin Kim (CBS 17)
Ted Yanagihara: Algorithm for Managing Anorectal Pain in Cancer Patients Undergoing Pelvic Radiotherapy – Ted Yanagihara (OncoDaily)
Oral Semaglutide (GLP-1) may reduce heart attack, stroke risk in diabetes patients – Dr. John Buse, Dr. Matthew Cavender (Consumer Affairs)
Clinical trial shows oral semaglutide vastly reduces heart attacks, strokes in people with type 2 diabetes – Dr. John Buse, Dr. Matthew Cavender (MSN.com)
Health Rounds: Semaglutide pill Rybelsus matches heart benefits of injectable versions – Dr. John Buse (Reuters)
A Full Breakdown of the Four Menstrual Cycle Phases – Dr. Crystal Schiller (Yahoo!Life)
HMN 2025: How Clinical trial exhibits oral semaglutide vastly reduces coronary heart assaults, strokes in folks with kind 2 diabetes – Dr. John Buse, Dr. Matthew Cavender (Health Medicine Network)
Semaglutide pill Rybelsus matches heart benefits of injectable versions – Dr. John Buse (The Economic Times)
Traditions are important during holiday season – Dr. Nadia Charguia (West Valley Utah News)